{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:08:19Z","timestamp":1790665699591,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arr.2023.102139","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:35:01Z","timestamp":1700760901000},"page":"102139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Circulating arginine metabolites in Alzheimer\u2019s disease and vascular dementia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"92","author":[{"given":"Angelo","family":"Zinellu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Sedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arduino A.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2023.102139_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neures.2023.01.010","article-title":"Determination of affected brain regions at various stages of Alzheimer's disease","volume":"192","author":"Ahmad","year":"2023","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.arr.2023.102139_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000144026","article-title":"Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease","volume":"26","author":"Arlt","year":"2008","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2023.102139_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1567205011310040001","article-title":"Asymmetric dimethylarginine: a possible link between vascular disease and dementia","volume":"10","author":"Asif","year":"2013","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2023.102139_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.niox.2023.03.003","article-title":"Dual role of nitric oxide in Alzheimer's disease","volume":"134\u2013135","author":"Azargoonjahromi","year":"2023","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.arr.2023.102139_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.arr.2023.102139_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.arr.2023.102139_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.mp.4002089","article-title":"Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease","volume":"14","author":"Bensemain","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2023.102139_bib8","article-title":"Emerging concepts in vascular dementia: a review","volume":"30","author":"Bir","year":"2021","journal-title":"J. Stroke Cereb. Dis."},{"key":"10.1016\/j.arr.2023.102139_bib9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-Boger","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.arr.2023.102139_bib10","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2023.102139_bib11","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1096\/fj.201901318R","article-title":"Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology","volume":"34","author":"Choi","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2023.102139_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.arr.2023.102139_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000466688","article-title":"Serum amino acid profiles in normal subjects and in patients with or at risk of alzheimer dementia","volume":"7","author":"Corso","year":"2017","journal-title":"Dement Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.arr.2023.102139_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.arr.2023.102139_bib15","first-page":"159","article-title":"Why is nitric oxide important for our brain?","volume":"30","author":"Dzoljic","year":"2015","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.arr.2023.102139_bib16","article-title":"Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: a monocentric cross-sectional study","volume":"131","author":"Erre","year":"2020","journal-title":"Micro Res."},{"key":"10.1016\/j.arr.2023.102139_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2014.09.024","article-title":"Symmetric dimethylarginine alters endothelial nitric oxide activity in glomerular endothelial cells","volume":"27","author":"Feliers","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.arr.2023.102139_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50205-0","article-title":"Targeted metabolomic analysis of nitric oxide\/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes","volume":"9","author":"Fleszar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2023.102139_bib19","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1016\/S0021-9258(18)37384-8","article-title":"Purification and molecular identification of two protein methylases I from calf brain. Myelin basic protein- and histone-specific enzyme","volume":"263","author":"Ghosh","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.102139_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/2045-9912.273957","article-title":"Nitric oxide detection methods in vitro and in vivo","volume":"9","author":"Goshi","year":"2019","journal-title":"Med Gas. Res."},{"key":"10.1016\/j.arr.2023.102139_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.fct.2013.07.013","article-title":"Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers","volume":"61","author":"Gubandru","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.arr.2023.102139_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(02)00095-2","article-title":"Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro","volume":"322","author":"Haas","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2023.102139_bib23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnen\/60.9.906","article-title":"Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease","volume":"60","author":"Heneka","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2023.102139_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.arr.2023.102139_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.arr.2023.102139_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.arr.2023.102139_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ph16060825","article-title":"Increased circulating ADMA in young male rats caused cognitive deficits and increased intestinal and hippocampal NLRP3 inflammasome expression and microbiota composition alterations: effects of resveratrol","volume":"16","author":"Hsu","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2023.102139_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.102139_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184592","article-title":"The second life of methylarginines as cardiovascular targets","volume":"20","author":"Jarzebska","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.102139_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnagi.2013.00017","article-title":"Pathology and pathogenesis of vascular cognitive impairment-a critical update","volume":"5","author":"Jellinger","year":"2013","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2023.102139_bib31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2174\/1567205013666160314150348","article-title":"Altered arginine metabolism in cells transfected with human wild-type beta amyloid precursor protein (betaAPP)","volume":"13","author":"Jesko","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2023.102139_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000504800","article-title":"Donepezil attenuates obesity-associated oxidative stress and central inflammation and improves memory deficit in mice fed a high-fat diet","volume":"48","author":"Jiang","year":"2019","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2023.102139_bib33","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/S0021-9258(18)62716-4","article-title":"Isolation and identification of N-G,N-G- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine","volume":"245","author":"Kakimoto","year":"1970","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.102139_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cger.2022.07.006","article-title":"Vascular and nonvascular mechanisms of cognitive impairment and dementia","volume":"39","author":"Kara","year":"2023","journal-title":"Clin. Geriatr. Med"},{"key":"10.1016\/j.arr.2023.102139_bib35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/STROKEAHA.122.041444","article-title":"Emerging roles of endothelial nitric oxide in preservation of cognitive health","volume":"54","author":"Katusic","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.arr.2023.102139_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23147","article-title":"Rivastigmine ameliorates indomethacin experimentally induced gastric mucosal injury via activating alpha7nAChR with inhibiting oxidative stress and apoptosis","volume":"36","author":"Khalaf","year":"2022","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.arr.2023.102139_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer's disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2023.102139_bib38","doi-asserted-by":"crossref","first-page":"H825","DOI":"10.1152\/ajpheart.00064.2021","article-title":"Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling","volume":"321","author":"Kopaliani","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.arr.2023.102139_bib39","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s10571-021-01101-7","article-title":"Divergent dimethylarginine dimethylaminohydrolase isoenzyme expression in the central nervous system","volume":"42","author":"Kozlova","year":"2022","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.102139_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.120.000212","article-title":"Specific lowering of asymmetric dimethylarginine by pharmacological dimethylarginine dimethylaminohydrolase improves endothelial function, reduces blood pressure and ischemia-reperfusion injury","volume":"376","author":"Lee","year":"2021","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.arr.2023.102139_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/molpharm.121.000394","article-title":"A recombinant dimethylarginine dimethylaminohydrolase-1-based biotherapeutics to pharmacologically lower asymmetric dimethyl arginine, thus improving postischemic cardiac function and cardiomyocyte mitochondrial activity","volume":"101","author":"Lee","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2023.102139_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1159\/000522294","article-title":"A therapeutic extracorporeal device for specific removal of pathologic asymmetric dimethylarginine from the blood","volume":"51","author":"Lee","year":"2022","journal-title":"Blood Purif."},{"key":"10.1016\/j.arr.2023.102139_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WCO.0000000000000904","article-title":"Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"34","author":"Leuzy","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2023.102139_bib44","article-title":"Cysteine-rich whey protein isolate (CR-WPI) ameliorates erectile dysfunction by diminishing oxidative stress via DDAH\/ADMA\/NOS pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.arr.2023.102139_bib45","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ajpath.2021.02.022","article-title":"Endothelial nitric oxide synthase-deficient mice: a model of spontaneous cerebral small-vessel disease","volume":"191","author":"Liao","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2023.102139_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/acn3.726","article-title":"A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease","volume":"6","author":"Lin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2023.102139_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911067","article-title":"Clinical trials of new drugs for vascular cognitive impairment and vascular dementia","volume":"23","author":"Linh","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.102139_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.freeradbiomed.2014.12.002","article-title":"Asymmetric dimethylarginine exacerbates Abeta-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.","volume":"79","author":"Luo","year":"2015","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.arr.2023.102139_bib49","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/gps.5355","article-title":"Circulating asymmetric dimethylarginine and cognitive decline: A 4-year follow-up study of the 1936 Aberdeen Birth Cohort","volume":"35","author":"Malden","year":"2020","journal-title":"Int J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2023.102139_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0065-2423(09)48003-X","article-title":"The emerging role of symmetric dimethylarginine in vascular disease","volume":"48","author":"Mangoni","year":"2009","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.arr.2023.102139_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/ageing\/afz083","article-title":"New horizons in arginine metabolism, ageing and chronic disease states","volume":"48","author":"Mangoni","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.arr.2023.102139_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1875318301808010034","article-title":"Altered plasma global arginine bioavailability ratio in early-stage Alzheimer\u2019s Disease","volume":"8","author":"Mart\u00ednez-Martos","year":"2018","journal-title":"Open Biomark. J."},{"key":"10.1016\/j.arr.2023.102139_bib53","first-page":"275","article-title":"Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia","volume":"26","author":"Mochizuki","year":"1996","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.arr.2023.102139_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s007020050057","article-title":"Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease","volume":"105","author":"Molina","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2023.102139_bib55","doi-asserted-by":"crossref","first-page":"14776","DOI":"10.1074\/jbc.REV119.006136","article-title":"Detection and quantification of nitric oxide-derived oxidants in biological systems","volume":"294","author":"Moller","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.102139_bib56","series-title":"Joanna Briggs Institute Reviewer\u2019s Manual","article-title":"Systematic reviews of etiology and risk","author":"Moola","year":"2017"},{"key":"10.1016\/j.arr.2023.102139_bib57","doi-asserted-by":"crossref","first-page":"2579S","DOI":"10.3945\/jn.115.226621","article-title":"Arginine metabolism revisited","volume":"146","author":"Morris","year":"2016","journal-title":"J. Nutr."},{"key":"10.1016\/j.arr.2023.102139_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psychres.2016.02.029","article-title":"Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment","volume":"238","author":"Nonaka-Hashida","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.arr.2023.102139_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19670-y","article-title":"Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer's disease (from the Nakayama Study)","volume":"12","author":"Ozaki","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2023.102139_bib60","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ 372"},{"key":"10.1016\/j.arr.2023.102139_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0301-0082(00)00044-7","article-title":"Nitric oxide as modulator of neuronal function","volume":"64","author":"Prast","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2023.102139_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38467-9","article-title":"A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase","volume":"14","author":"Ragavan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.102139_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcn\/80.2.483","article-title":"Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease","volume":"80","author":"Ravaglia","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"Pt 2","key":"10.1016\/j.arr.2023.102139_bib64","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/bj3000483","article-title":"Purification and characterization of S-adenosylmethionine-protein-arginine N-methyltransferase from rat liver","volume":"300","author":"Rawal","year":"1994","journal-title":"Biochem J."},{"key":"10.1016\/j.arr.2023.102139_bib65","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1476-5381.1990.tb14151.x","article-title":"Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo","volume":"101","author":"Rees","year":"1990","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2023.102139_bib66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1567205011666140131121739","article-title":"Impaired renal function and biomarkers of vascular disease in Alzheimer's disease","volume":"11","author":"Richardson","year":"2014","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2023.102139_bib67","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846714","article-title":"Setbacks and promises for drugs against Alzheimer's disease: as pharmaceutical companies are retreating from drug development for Alzheimer's, new approaches are being tested in academia and biotech companies","volume":"19","author":"Rinaldi","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.arr.2023.102139_bib68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000502","article-title":"Emerging molecular mechanisms of vascular dementia","volume":"26","author":"Romay","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.arr.2023.102139_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135254","article-title":"Changes in arginine metabolism in advanced Alzheimer's patients: experimental and theoretical analyses","volume":"1282","author":"Sar\u0131","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.arr.2023.102139_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejphar.2007.12.009","article-title":"Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice","volume":"581","author":"Saxena","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.arr.2023.102139_bib71","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2023.102139_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119129","article-title":"A review on advances of treatment modalities for Alzheimer's disease","volume":"276","author":"Se Thoe","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2023.102139_bib73","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(03)00007-1","article-title":"Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease","volume":"24","author":"Selley","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.102139_bib74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2018.09.046","article-title":"Paroxetine and rivastigmine mitigates adjuvant-induced rheumatoid arthritis in rats: Impact on oxidative stress, apoptosis and RANKL\/OPG signals","volume":"212","author":"Shafiey","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2023.102139_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030416","article-title":"Arginine metabolites as biomarkers of myocardial ischaemia, assessed with cardiac magnetic resonance imaging in chronic kidney disease","volume":"11","author":"Shah","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2023.102139_bib76","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/156720510791383822","article-title":"The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy","volume":"7","author":"Sinem","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2023.102139_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2019.02.004","article-title":"A diethylpyrocarbonate-based derivatization method for the LC-MS\/MS measurement of plasma arginine and its chemically related metabolites and analogs","volume":"492","author":"Sotgia","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2023.102139_bib78","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.arr.2023.102139_bib79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00726-013-1556-3","article-title":"Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)","volume":"45","author":"Strobel","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2023.102139_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9030092","article-title":"Toxic dimethylarginines: asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA)","volume":"9","author":"Tain","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.arr.2023.102139_bib81","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.freeradbiomed.2010.06.029","article-title":"Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine","volume":"49","author":"Tain","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.arr.2023.102139_bib82","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","article-title":"Challenges and hopes for Alzheimer's disease","volume":"27","author":"Tatulian","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2023.102139_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116224","article-title":"Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects","volume":"23","author":"Tian","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.102139_bib84","first-page":"15","article-title":"Assessing the influence of a single study in the meta-analysis estimate","volume":"47","author":"Tobias","year":"1999","journal-title":"Stata Tech. Bull."},{"key":"10.1016\/j.arr.2023.102139_bib85","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.freeradbiomed.2022.11.022","article-title":"Nitric oxide\/cGMP\/CREB pathway and amyloid-beta crosstalk: from physiology to Alzheimer's disease","volume":"193","author":"Tropea","year":"2022","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.arr.2023.102139_bib86","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/10715760500053651","article-title":"Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids","volume":"39","author":"Tsikas","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.arr.2023.102139_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00927-z","article-title":"The Alzheimer's disease drug development landscape","volume":"13","author":"van Bokhoven","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2023.102139_bib88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2015.05.014","article-title":"Targeted arginine metabolomics: a rapid, simple UPLC-QToF-MS(E) based approach for assessing the involvement of arginine metabolism in human disease","volume":"447","author":"van Dyk","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2023.102139_bib89","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/00365519609090591","article-title":"Nitric oxide as a challenge for the clinical chemistry laboratory","volume":"56","author":"Viinikka","year":"1996","journal-title":"Scand. J. Clin. Lab Invest"},{"key":"10.1016\/j.arr.2023.102139_bib90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/17425250902785172","article-title":"Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease","volume":"5","author":"Wadham","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.arr.2023.102139_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Method."},{"key":"10.1016\/j.arr.2023.102139_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00376","article-title":"Dysfunction of cerebrovascular endothelial cells: prelude to vascular dementia","volume":"10","author":"Wang","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2023.102139_bib93","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fncel.2015.00322","article-title":"Implications of glial nitric oxide in neurodegenerative diseases","volume":"9","author":"Yuste","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.arr.2023.102139_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020151","article-title":"Drug discovery and development targeting dementia","volume":"16","author":"Zagorska","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2023.102139_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094540","article-title":"The roles of nitric oxide synthase\/nitric oxide pathway in the pathology of vascular dementia and related therapeutic approaches","volume":"22","author":"Zhu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.102139_bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2014.07.013","article-title":"Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: a controlled study","volume":"220","author":"Zincir","year":"2014","journal-title":"Psychiatry Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723002982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723002982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:18:42Z","timestamp":1761592722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163723002982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":96,"alternative-id":["S1568163723002982"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2023.102139","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating arginine metabolites in Alzheimer\u2019s disease and vascular dementia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2023.102139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102139"}}